 |
bedaquiline; (1R,2S) 6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-(1-naphthyl)-beta-phenyl-3-quinolineethanol |
|---|---|
| Trade Name | Sirturo |
| Orphan Indication | Active tuberculosis |
| USA Market Approval | USA |
| USA Designation Date | 2005-01-10 00:00:00 |
| Sponsor | Janssen Research & Development, LLC;920 Route 202 South;Raritan, New Jersey, 08869 |
